Leadership

Management has executed a multi-year portfolio simplification and cost-reset, but the benefits have not yet translated into durable peer-leading profitability.

Leadership has communicated a turnaround-oriented agenda, yet negative TTM ROE indicates the operating improvements have not consistently converted into shareholder returns.

Compared with more disciplined medtech peers, AVNS leadership appears more reactive than proactive, with value creation still dependent on continued execution rather than proven compounding.

Execution

Operational execution has improved enough to support a low leverage profile, but the negative TTM ROE shows the earnings base remains insufficiently stable.

Management has reduced balance-sheet risk, and net debt to EBITDA below zero suggests cash generation has outpaced debt, but profitability remains inconsistent.

Relative to peers with steadier margin and return profiles, AVNS has shown partial execution progress without sustained evidence of repeatable outperformance.

Capital Allocation

Management has preserved financial flexibility by keeping debt-to-equity low, which supports resilience but also signals limited evidence of aggressive value-creating deployment.

The negative net debt position indicates prior allocation favored deleveraging and liquidity, yet weak ROE suggests capital has not been converted into strong returns.

Versus peers that consistently reinvest at high returns, AVNS appears more conservative and balance-sheet focused than clearly accretive in capital deployment.

Incentives

Incentive quality appears only moderately effective because management actions have emphasized restructuring and balance-sheet repair more than sustained return expansion.

The persistence of negative ROE suggests compensation alignment has not yet produced consistently superior economic outcomes for shareholders.

Compared with better-aligned peers, AVNS shows no clear evidence from outcomes that incentives are driving elite long-term capital efficiency.

Overall Score

AVNS management appears disciplined on balance-sheet risk and restructuring, but weak profitability and only partial execution keep overall quality below stronger peers.

Score Driver: Negative TTM ROE Despite Low Leverage